Skip to main content
Equibles
CBUS logo

CBUS · Cibus, Inc. · Metrics

Track CBUS — free

Use CBUS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.60 -0.01 (-0.62%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$124.58M
Shares
76.43M

CBUS metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.61
Market cap
$124.58M

Price action

20 metrics
Price change (1W)
-3.6%
Price change (30D)
-16.8%
Price change (3M)
+23.3%
Price change (6M)
-49.7%
Price change (YTD)
-8.6%
Price change (1Y)
+26.2%
Trailing year
Price change (5Y)
—
52-week high
$4.05
52-week low
$1.16
Change from 52-week high
-60.7%
Change from 52-week low
+37.1%
Annualized volatility
108.1%
Annualized volatility (3M)
82.5%
Beta
2.2
RSI (14D)
39.2
Price vs SMA 50
-9.4%
Price vs SMA 200
-15.3%
Avg volume (3M)
281,357
Relative volume
0.3
Average dollar volume
$491,299

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
76.43M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
28.7×
reciprocal yield 3.5%
P / book
8.4
reciprocal yield 11.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-78.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-31.4×
EV / revenue historical average (5Y)
-31.4×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
—
Operating margin
-1,450.6%
Trailing 12 months
Net margin
-2,258.9%
Gross profit (TTM)
$167,000
Operating profit (TTM)
−$63.06M
Net income (TTM)
−$98.19M
Trailing 12 months
Diluted EPS (TTM)
$-1.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.93

Growth

11 metrics
Revenue growth YoY
+6.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.35M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+84.4%
Year over year · more shares
Revenue CAGR (3Y)
+185.1%
Revenue CAGR (5Y)
-31.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-663.4%
Return on assets
-31.3%
Debt / equity
0.1
Current ratio
1.6
EBITDA (TTM)
−$57.98M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$20.43M
Total assets
$313.45M
Total debt
$865,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$46.05M
Capital expenditures (TTM)
$267,000
R&D (TTM)
$37.39M
SG&A (TTM)
$20.89M
Stock compensation (TTM)
$6.77M
R&D / revenue
860.2%
Stock compensation / revenue
155.6%

Ownership (13F)

3 metrics
13F filers
63
13F filer change QoQ
-6
Institutional ownership
24.3%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 19.1 days to cover
Days to cover
19.1d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1705843 CUSIP 17166A101 13F (30d) 56 filings 47 filers Visit website Investor relations